Abstract:Factor-based induced reprogramming approaches have tremendous potential for human regenerative medicine, but the efficiencies of these approaches are still low. In this study, we analyzed the global transcriptional profiles of mouse induced pluripotent stem cells (miPSCs) and mouse embryonic stem cells (mESCs) from seven different labs and present here the first successful clustering according to cell type, not by lab of origin. We identified 2131 different expression genes (DEs) as candidate pluripotency-associated genes by comparing mESCs/miPSCs with somatic cells and 720 DEs between miPSCs and mESCs. Interestingly, there was a significant overlap between the two DE sets. Therefore, we defined the overlap DEs as “consensus DEs” including 313 miPSC-specific genes expressed at a higher level in miPSCs versus mESCs and 184 mESC-specific genes in total and reasoned that these may contribute to the differences in pluripotency between mESCs and miPSCs. A classification of “consensus DEs” according to their different expression levels between somatic cells and mESCs/miPSCs shows that 86% of the miPSC-specific genes are more highly expressed in somatic cells, while 73% of mESC-specific genes are highly expressed in mESCs/miPSCs, indicating that the miPSCs have not efficiently silenced the expression pattern of the somatic cells from which they are derived and failed to completely induce the genes with high expression levels in mESCs. We further revealed a strong correlation between oocyte-enriched factors and insufficiently induced mESC-specific genes and identified 11 hub genes via network analysis. In light of these findings, we postulated that these key hub genes might not only drive somatic cell nuclear transfer (SCNT) reprogramming but also augment the efficiency and quality of miPSC reprogramming.

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit

Genome-wide gain-of-function screen identifies novel regulators of pluripotency.

Network plasticity of pluripotency transcription factors in embryonic stem cells

Genome-Wide CRISPR Screen Identifies Puf60 As a Novel Stemness Gene of Mouse Embryonic Stem Cells

Parallel genome-scale CRISPR screens distinguish pluripotency and self-renewal

A high throughput CRISPR perturbation screen identifies epigenetic regulators impacting primordial germ cell development

A high‐throughput screen in mESCs to identify the cross‐talk between signaling, endocytosis, and pluripotency

Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells

Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency

Defining Essential Enhancers for Pluripotent Stem Cells Using a Features-Oriented CRISPR-Cas9 Screen

A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness

Screening for genes essential for mouse embryonic stem cell self-renewal using a subtractive RNA interference library.

A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs

Single-cell Analyses of X Chromosome Inactivation Dynamics and Pluripotency During Differentiation.

Mapping germ-layer specification preventing genes in hPSCs via genome-scale CRISPR screening

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

Use of genome-wide RNAi screens to identify regulators of embryonic stem cell pluripotency and self-renewal.

Genome-scale screening in a rat haploid system identifies <i>Thop1</i> as a modulator of pluripotency exit